Electrochemical Behavior of Atorvastatin at Glassy Carbon Electrode and its Direct Determination in Pharmaceutical Preparations by Square Wave and Differential Pulse Voltammetry


YILMAZ B., KABAN S.

INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES, cilt.78, sa.3, ss.360-367, 2016 (SCI-Expanded) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 78 Sayı: 3
  • Basım Tarihi: 2016
  • Doi Numarası: 10.4172/pharmaceutical-sciences.1000126
  • Dergi Adı: INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.360-367
  • Anahtar Kelimeler: Atorvastatin, cyclic voltammetry, square wave voltammetry, differential pulse voltammetry, glassy carbon electrode, COA REDUCTASE INHIBITOR, BIOLOGICAL-FLUIDS, DOSAGE FORMS, HUMAN PLASMA, HYPERCHOLESTEROLEMIA, OXIDATION, EFFICACY, SAFETY
  • Atatürk Üniversitesi Adresli: Evet

Özet

A simple and rapid electrochemical method for the determination of atorvastatin in pharmaceutical preparations was developed. The anodic peak at 1.07 V obtained in a buffer on glassy carbon electrode was used for analysis. The peak current and peak potential depends on pH, scan rate and initial potential. Decrease of the anodic peak with increasing pH, as well as deviations from linear plots of ip= f(C) and i= kv(1/2) indicate that this peak at higher concentrations is affected by adsorption-desorption phenomena. The calibration curves were linear for atorvastatin at the concentration range of 1-50 mu g/ml or square wave and differential pulse voltammetry methods, respectively. Intra and interday precision values for atorvastatin were less than 3.17, and accuracy (relative error) was better than 1.93%. The mean recovery of atorvastatin was 100.4% for pharmaceutical preparations. Limits of detection were 0.3 mu g/ml and 0.2 mu g/ml for square wave and differential pulse voltammetry, respectively. Developed methods in this study are accurate, precise and can be easily applied to Ator, Cholvast and Lipitor tablets as pharmaceutical preparation.